舊藥新用：首款FDA核准藥物藉由抑制IRAK4及其訊息傳遞途徑達到抗發炎之效用

完整後設資料紀錄

DC 欄位	值	語言
dc.contributor.author	沈培鈞	en_US
dc.contributor.author	Shen, Pei-Chun	en_US
dc.contributor.author	楊進木	en_US
dc.contributor.author	Yang, Jinn-Moon	en_US
dc.date.accessioned	2015-11-26T01:02:03Z	-
dc.date.available	2015-11-26T01:02:03Z	-
dc.date.issued	2015	en_US
dc.identifier.uri	http://140.113.39.130/cdrfb3/record/nctu/#GT070257206	en_US
dc.identifier.uri	http://hdl.handle.net/11536/127154	-
dc.language.iso	zh_TW	en_US
dc.subject	舊藥新用	zh_TW
dc.subject	蛋白質激酶抑制劑	zh_TW
dc.subject	抗發炎反應	zh_TW
dc.subject	同源藥理	zh_TW
dc.subject	Drug repurposing	en_US
dc.subject	Protein kinase inhibitor	en_US
dc.subject	Anti-inflammation	en_US
dc.subject	Homopharma	en_US
dc.title	舊藥新用：首款FDA核准藥物藉由抑制IRAK4及其訊息傳遞途徑達到抗發炎之效用	zh_TW
dc.title	Drug repurposing: the first FDA drug inhibits IRAK4 and pathways for anti-inflammation	en_US
dc.type	Thesis	en_US
dc.contributor.department	生物資訊及系統生物研究所	zh_TW
顯示於類別：	畢業論文